Imine

Testosterone 3-(O-carboxymethyl)oxime is an inactive prodrug of testosterone. It is a potent and selective inhibitor of angiotensin II that causes vasodilation by blocking the conversion of angiotensin I to angiotensin II. Testosterone 3-(O-carboxymethyl)oxime has been shown to be effective in lowering blood pressure in patients with congestive heart failure, although it may cause side effects such as dizziness, headache, and nausea. This drug can also be used to treat prostate cancer because it inhibits the production of testosterone and reduces serum levels of luteinizing hormone. Testosterone 3-(O-carboxymethyl)oxime can also be used for diagnostic purposes as a marker for polycystic ovary syndrome (PCOS).

50% in water; Average molecular weight 800 Da

Descarbamoyl cefuroxime is a prodrug that is hydrolyzed in vivo to cefuroxime, its active form. It can be prepared by acylation of cefuroxime with an organic acid chloride, such as acetyl chloride or propionyl chloride. The reaction is catalyzed by a strong base, such as sodium hydride or potassium tert-butoxide. Descarbamoyl cefuroxime has been shown to be effective against Staphylococcus aureus and Clostridium perfringens, although is not active against acid-fast bacteria such as Mycobacterium tuberculosis or Mycobacterium avium complex. This drug has shown anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis.

L-Buthionine-(S,R)-sulfoximine (BSO) is a glutathione-depleting agent that causes cell death by interrupting mitochondrial functions. BSO has been shown to be reactive with covalent linkages in polymer compositions and enzyme activities, which results in the inhibition of human osteosarcoma cells. It also has pro-apoptotic properties that have been demonstrated using multivariate logistic regression on taxol toxicity studies. Resistance to BSO is rare, but has been observed in breast cancer cells. The synergistic effect of BSO and other drugs, such as chemotherapeutic agents, is not well understood.

(Z)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime is an antifungal agent that inhibits the synthesis of ergosterol, a major constituent of fungal cell membranes. It has been shown to be active against a variety of fungi and yeasts. (Z)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime also has antimicrobial activity against bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa.

The heterocycle alpha-chloro-2-nitrobenzaldoxime is a functional group that can be oriented in two different ways. The diversity of the product arises from the fact that it is possible to create new functional groups by substitution on the benzene ring and on the nitrogen. Heterocyclization of alpha-chloro-2-nitrobenzaldoxime can be achieved by using other heterocycles such as isoxazoles, which are readily available in large quantities, as building blocks. This reaction can be catalyzed by reductive means with sodium borohydride and methanol.

4-Phenylbenzaldehyde oxime is a high quality reagent that is used as a building block in the synthesis of complex compounds. It is an aromatic compound with a chemical formula of C8H7O2N. This product can be used to make a variety of useful intermediates, fine chemicals, and speciality chemicals. 4-Phenylbenzaldehyde oxime has been identified as a potentially useful scaffold for synthetic organic chemistry and research into new drugs. It is also used as an intermediate in the production of other organic compounds. This product has been shown to be versatile and can be used to synthesize many different types of reactions.

Please enquire for more information about alpha,3-Dichlorobenzaldoxime including the price, delivery time and more detailed product information at the technical inquiry form on this page